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Abstract: Enterotoxigenic Escherichia coli (ETEC) is the main infectious agent responsible for piglet
post-weaning diarrhea with high mortality rates. Antimicrobials represent the current principal strat-
egy for treating ETEC infections in pig farms, but the occurrence of multi-resistant bacterial strains
has considerably increased in the last decades. Thus, finding non-antibiotic alternatives becomes a
real emergency. In this context, we investigated the effect of a live yeast strain, Saccharomyces cerevisiae
var boulardii CNCM I-1079 (SB) in an in vitro model of the weaning piglet colon implemented with
a mucus phase (MPigut-IVM) inoculated with ETEC and coupled with an intestinal porcine cell
line IPI-2I. We showed that SB was able to modulate the in vitro microbiota through an increase
in Bacteroidiaceae and a decrease in Prevotellaceae families. Effluents collected from the SB treated
bioreactors were able to mitigate the expression level of genes encoding non-gel forming mucins, tight
junction proteins, innate immune pathway, and pro-inflammatory response in IPI-2I cells. Further-
more, SB exerted a significant protective effect against ETEC adhesion on porcine IPEC-J2 intestinal
cells in a dose-dependent manner and showed a positive effect on ETEC-challenged IPEC-J2 by
lowering expression of genes involved in pro-inflammatory immune responses. Our results showed
that the strain SB CNCM I-1079 could prevent microbiota dysbiosis associated with weaning and
protect porcine enterocytes from ETEC infections by reducing bacterial adhesion and modulating the
inflammatory response.
Keywords: in vitro model of colonic microbiota; intestinal cells; piglet; weaning; probiotics; ETEC
1. Introduction
Enterotoxigenic Escherichia coli (ETEC) is the main pathogen responsible of post-
weaning diarrhea [1–3]. ETEC prevalence has been estimated to 60 to 80 % of piglets
between day 1 and 4 post-weaning [4]. The economic losses associated with ETEC infec-
tions in swine industry are estimated between 40 and 314 € per sow depending on the
country and breeding conditions [1]. To treat post-weaning ETEC infections, antibiotics
are, up to date, successfully used but raise major public health concerns due to the wide
spread of antibiotic resistance genes in livestock production and globally in the environ-
ment in the last decades [1,5]. One of the next challenges of the swine industry is to
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find non-pharmacological alternatives to reduce the incidence of post-weaning diarrhea
while decreasing the use of antibiotics in order to fight against the worrying increase of
bacterial resistance towards antibiotics [5]. Probiotics could be potential candidates to
help animals resist infections. Probiotics are living organisms that, when administered
in adequate amounts, have the potential to confer health benefits to their hosts [6]. If
most of the characterized probiotics belong to the bacterial domain such as Lactobacillus
or Bifidobacterium species, yeasts Saccharomyces cerevisiae var. boulardii (SB) have shown
to yield numerous positive effects for animal health, including, for example, better feed
efficiency and digestibility, reduced diarrhea, or reduced intestinal inflammation [2–5]. In
livestock production, yeasts have been already commercialized as feed additives which
may be able to replace the use of antibiotics as growth promoters [7] but also have been
shown to modulate intestinal microbiota, reduce fecal ETEC shedding, decrease diarrhea
symptoms, or improve intestinal morphology [7–14]. In vitro trials started to give insights
about S. cerevisiae and SB anti-infectious properties. In porcine intestinal cell lines chal-
lenged with ETEC strains, S. cerevisiae and SB were both able to inhibit the expression
of pro-inflammatory cytokines induced by ETEC infection [12,15]. However, further in-
vestigations are needed to unravel the yeast mode of action and beneficial effects as feed
additive for weaning piglets.
In this study, we used an in vitro gut fermentation model of the weaning piglet colon
(MPigut-IVM) which was recently set-up [16,17] to track the influence of SB CNCM I-1079
on the composition and activity of the resident microbiota challenged with an ETEC F4+
(K88) strain isolated from a diarrheic piglet. Fermentation supernatants were also used to
evaluate if the introduction of SB CNCM I-1079 into the in vitro model could affect gene
expression of an intestinal porcine cell line. In parallel, we evaluated the direct effects
of this live yeast on bacterial adhesion and gene expression of intestinal porcine cells
challenged by the ETEC strain.
2. Results
2.1. SB CNCM I-1079 Inhibits ETEC Adhesion and ETEC-Induced Inflammatory Response on
IPEC-J2 Intestinal Cells
ETEC adherent to IPEC-J2 cells were detected at an average of 1.1× 107, 4.3× 106, and
3.5 × 107 cells/mL, respectively, for the three biological replicates and normalized to 100%.
The pre-treatment of IPEC-J2 cells with live SB CNCM I-1079 significantly (p < 0.05) reduced
ETEC Ec105 adhesion, in a dose-dependent fashion, to reach, respectively, 69 ± 19.7,
53 ± 17.7, and 13 ± 1.2% adhesion for the 106, 107, and 108 SB doses (Figure 1). Moreover,
SB also changed the gene expression profile in IPEC-J2 in a dose-dependent manner
(Figure 2). For instance, the highest dose of SB significantly reduced the expression of
CCL20, CXCL2, IL1a, IL6, IL8, TNFα, or TLR4 genes of, respectively,−4.2± 1.5,−6.2± 1.6,
−6.1 ± 1.7, −1.8 ± 0.3, −4.9 ± 0.1, −2 ± 1, and −1 ± 0.3 Log2fold changes comparatively
to infected cells which had not been exposed to SB (Figure 2). All pre-treatments slightly,
but yet significantly, increased the expression of MUC1 gene.
2.2. Live SB CNCM I-1079 Impacts Microbiota Composition and Activity of the Mpigut-IVM
Challenged with a Feed Deprivation Stress, a Dietary Change and an ETEC Strain
2.2.1. Effects of SB on ETEC Colonization in the MPigut-IVM
The quantification of the ETEC LT (labile enterotoxin) gene was used to monitor the
presence of the inoculated ETEC strain in the MPigut-IVM and the impact of SB preventive
treatment. Overall, the LT gene concentration decreased over time during fermentation
whatever the condition, but more quickly in the RUN A where it reached 4 Log10 copy
numbers/g of content in the bead medium on day 15 compared to the RUN B in which it
was maintained at 8 Log10 copy numbers/g (Figure 3).
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Figure 1. Percentage of adherent ETEC cells on IPEC-J2 intestinal cells pre-treated or not with dif-
ferent doses of SB CNCM I-1079. The concentration of ETEC adherent cells on control IPEC-J2 cells 
(non-treated with SB yeasts) was normalized to 100% (n = 3). The denominations e6, e7, and e8, 
respectively, correspond to the doses of 106, 107, and 108 CFU/well of SB incubated on the ETEC-
challenged IPEC-J2 cells (pvalue codes: *** < 0.000). 
Figure 1. Percentage of adherent ETEC cells on IPEC-J2 intestinal cells pre-treated or not with
different doses of SB CNCM I-1079. The concentration of ETEC adherent cells on control IPEC-J2
cells (non-treated with SB yeasts) was normalized to 100% (n = 3). The denominations e6, e7, and
e8, respectively, correspond to the doses of 106, 107, and 108 CFU/well of SB incubated on the
ETEC-challenged IPEC-J2 cel s (p value codes: *** <0.000).
2.2.2. Effects of SB on Gut Microbiota Activity
The average total SCFA concentration was higher in the bioreactor medium in the
presence of SB compared to ETEC alone (Figure 4). No difference with SB supplementation
was noticed on the proportions of the SCFAs measured in the bioreactor medium nor in the
bead medium (Supplementary Figure S1). At day 10, at the time of ETEC inoculation an
increase in hydrogen proportion was noticed in the SBETEC condition (13.2%) compared
to the ETEC condition (4.4%) as well as a decrease in methane proportion from 6.9% in the
ETEC condition to 2.8% in the SBETEC condition but the gas mixture recovered similar
profiles later on (Figure S2).
2.2.3. Effects of SB on Microbiota Composition
At the phylum level, the bacterial composition of the in vitro microbiota of the MPigut-
IVM challenged with a feed-deprivation stress, a dietary change, and an ETEC strain, and
supplemented or not with SB, displayed quite similar profiles in both the bioreactor
medium and the mucin beads, with Bacteroidetes and Firmicutes largely dominant, and
Proteobacteria, Actinobacteria, Spirochaetes, and Synergistes as minor phyla (Figure S3).
No difference was observed in alpha diversity indexes between the ETEC and SBETEC
conditions (data not shown). At the family level, the most distinguishable result was the
higher relative abundance of Bacteroidiaceae and the lower Prevotellaceae during the recovery
period in the SBETEC compared to the ETEC condition, especially in the bioreactor medium
(Figure S4). At the genus level, in the bioreactor medium the main difference observed
between SBETEC and ETEC conditions was an evolution of the Bacteroides/Prevotella
ratio (Figure 5A). Indeed, the mean relative abundances of Bacteroides and Prevotella 7 and
9 genera were, respectively, 16.1% and 13.7% for the ETEC condition while they were
23% and 7.5% in the SBETEC condition from day 10 to day 15. In the bioreactor medium,
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other differences were noticed such as a higher relative abundance of Tyzzerella, Citrobacter,
Enterococcus at day 9, Eubacterium nodatum group at day 9, Escherichia/Shigella at day 15,
Ruminococcus 2 at days 7 and 15 and Roseburia from day 9 to day 15 in SB inoculated
fermenters (Figure 5A). On the mucin beads, when SB was distributed daily to the MPigut-
IVM and compared to control ETEC bioreactors, we measured higher relative abundances
of Streptococcus, Enterococcus, Ruminococcus gauvreauii group, and Pyramidobacter at day 15,
Treponema 2 at days 7 and 9, an average higher relative abundance of Escherichia/Shigella
and a lower relative abundance of Prevotella 7 after the feed-deprivation period, with quite
important discrepancies between runs (Figure 5B).
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 Figure 5. Mean relative abundances of the 30 main bacterial genera in the bioreactor medium (A) on
the mucin beads (B) of the MPigut-IVM during the ETEC and SBETEC conditions.
Regarding archaeal microbiota, SB supplementation promoted the relative abundance
of Methanobrevibacter at the expense of Methanosphaera during the recovery period in
particular in the Run B and in the bioreactor medium only (Figure S5).
Saccharomyces cerevisiae was detected only in the SBETEC condition, with high but
variable concentrations in the bioreactor medium especially after feed-deprivation stress
(6 to 10 Log10/g), quite high and very stable concentrations (6 Log10/g) in the mucin bead
medium, and much lower ones on mucin beads (less than 2 Log10/g). The concentrations
of targeted bacterial and archaeal groups were not impacted by SB supplementation
(Figure S6).
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2.3. SB Live Yeast Supplementation to ETEC-Challenged Mpigut-IVM Leads to Changes in Gene
Expression Profile of IPI-2I Intestinal Cells
In the presence of supernatants collected from the bead medium of the bioreactors
challenged with ETEC and receiving a daily dose of SB, the expression of the genes encoding
TNFα, MYD88, CLDN4, and MUC1 in IPI-2I cells was reduced at day 15 when compared
to supernatants collected from non-supplemented bioreactors (Figure 6). On the opposite,
the IL8 gene expression was increased in the presence of supernatants from the SBETEC
condition compared to the ETEC condition at days 13 and 15.
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3. Discussion
ETEC is the most common cause of diarrhea in farm animals [3,18]. In the last decades,
common stra egies to fight against infectious post-we ning diarrhea revolved in the use
of antibiotics a efficient preventive and curative treatments, however, this massive util-
isati n is not su t inable due to the ncreasing diss min tion of resistant genes among
bacteria [5,19]. More a d more investigations now focus on finding non-pharmacological
preventive and therapeutic solutions, such as probi tic-based strategies. Sever l studies
highlight d tha st ins from the Saccharomyces genus could be potential candidates for
reducing ETEC colonizati n and signs of inf ctio s in weaning piglets [11,20,21]. Sac-
charomyces yeasts showed be eficial impact on several bacterial infections such as t e
inhibition of Citrobacter rodentium adhesion to mice olonic epithelium [22], t i i i-
ti f Clostridium difficile toxin production in rat ileum the modulation of ETEC-induced
mitogen activated protein pathway on T84 human intestinal cells, and the modulation
of pro-inflammatory cellular response in Shigella infections via the secretion of proteases
degrading pathogen toxins and receptors on T84 intestinal cells [23–25]. Another potential
mode of action of probiotic yeasts could be the modulation of the intestinal microbiota
of piglets at weaning, as already demonstrated in in vivo studies [14]. In the challenged
MPigut-IVM with the ETEC F4 porcine strain, the results from two independent biological
replicates suggest that the daily supplementation of SB seemed to favour the relative abun-
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dance of Bacteroides while reducing Prevotella members after in vitro simulation of weaning
transition [16,17]. As a decrease in relative abundance of Bacteroidiaceae in fecal microbiota
was previously considered as the onset of post-weaning diarrhea in piglets [26], an increase
in Bacteroides with SB supplementation may help to limit the intestinal microbiota dysbiosis
associated with weaning transition. Bacteroides genus is considered as one of the major
genera of the core microbiota of mammals particularly known for their strong polysac-
charide degradation systems and their beneficial interactions with their host [27]. Studies
performed on human microbiota reported that members of Bacteroides genus demonstrated
their ability to treat intestinal colitis, immune dysfunctions, and metabolic disorders and
are considered as potential next-generation of probiotics [27]. SB supplementation to the
MPigut-IVM also increased the relative abundance of Escherichia/Shigella genus, which was
not correlated with a higher detection of the LT toxin gene, suggesting that the members of
this group would belong to non-pathogenic commensal species. A low relative abundance
of commensal E. coli has been associated with a higher incidence of piglet post-weaning
diarrhea [28]. Thus, the increase of commensal Escherichia/Shigella that we observed with
SB treatment could promote ETEC ecological niche filling by commensal E. coli and thereby
would constitute a protective effect against ETEC colonization in the gut of newly weaned
piglets. In agreement with this hypothesis, Bin et al. highlighted that the relative abun-
dance of E. coli was increased from 49% to 86% in the jejunum of ETEC-challenged piglets
who remained healthy compared to diarrheic individuals [29]. This finding was also
supported by Yang et al. who reported that E. coli was decreased in the fecal microbiota
of pre-weaned diarrheic piglets [28]. In addition, the well-known probiotic E. coli Nissle
1917 has shown efficient suppression of clinical signs against ETEC-induced diarrhea in
an infection model of pre-weaned piglets [30]. Deeper analysis of E. coli strain diversity
within in vitro gut microbiota, in particular regarding virulence factors or metabolic traits,
would deserve further studies [31]. In addition, there were differences between the two
runs in the microbiota responsiveness to the applied stressors and probiotics, that were
probably linked to the composition of the initial fecal inoculum, as observed earlier [16,17].
Being able to study individual variability and susceptibility to a given treatment represents
an important advantage, nonetheless more research would be needed to confirm the effects
of SB treatment with more replicates. Beneficial SCFA producers [32], were also increased
by SB treatments in the MPigut-IVM which could help to fight against dysbiosis and ETEC
colonization by ensuring an efficient microbiota functionality. A higher mean of total SCFA
concentration was indeed detected every day in the SBETEC condition compared to ETEC
condition in the bioreactor medium.
The MPigut-IVM proves to be a relevant tool to assess the effects of probiotics. How-
ever, a limitation of the developed model is the absence of host-microbiota crosstalk or
immune regulations, which are of importance when evaluating the effects of probiotics.
Indeed, modifications of gut microbiota composition and activity induced by SB in the
MPigut-IVM could have an impact on host cell metabolism or inflammatory response.
To try to address this question, in our study we investigated the effects of supernatants
from the ETEC-challenged MPigut-IVM bead medium supplemented or not with SB on
gene expression in porcine IPI-2I cells. Supernatants from the SB supplemented group
seemed to mitigate the expression of TNFα, MyD88, CLDN4, and MUC1 genes that were
actually increased in the presence of ETEC, which returned to levels measured in non-ETEC-
challenged samples in our previous study [16]. IL8 gene expression was down-regulated
by the ETEC-challenged samples, and the SB supplementation seemed to restore basal gene
expression of the cells. Although results from the literature about the effects of probiotics
on host inflammatory genes are sometimes contradictory [11,33–35], in vivo and in vitro
studies reported some immunomodulatory effects of Saccharomyces species [4]. Wang et al.
reported that SB supplementation could reduce the level of TNFα in mice colon [36]. Dogs
which received S. cerevisiae fermentation products also displayed a lower level of TNFα in
their blood [37]. Saegusa et al. reported that, in presence of butyrate, S. cerevisiae treatment
of Caco-2 cells enhanced IL8 production suggesting that some yeasts, hypothetically due
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to their cell wall component rich in glucans, are able to stimulate the immune system of
the host via the increased production of specific cytokines [33]. This last result matches
with the higher level of IL8 gene expression that we observed in our IPI-2I cells incubated
with MPigut-IVM samples, which also contained butyrate. The slight activation of IL8
gene expression thus does not suggest necessarily that SB provokes inflammation, which
would be somewhat contradictory with the decrease in TNFα and MyD88 gene expression.
These data also corroborate that the immunomodulatory effects of SB could be influenced
by microbial activity (and especially SCFA production, in particular butyrate), however
yeast modes of action are far from being fully understood and further studies are needed to
understand the complex molecular mechanisms of the dialogue between SB, gut microbiota,
and the host. Our results show that the MPigut-IVM can be considered as an effective tool
to evaluate the effects of gut microbiota modulation due to pathogens and/or probiotics or
other compounds on intestinal epithelial cell response.
After entering orally into the piglet digestive tract, ETEC can attach to enterocytes
using fimbrial adhesins [38]. The fimbriae 4 colonization factor is the most prevalent among
ETEC responsible for post-weaning diarrhea in piglets [3]. As we wanted to confirm the
efficiency of SB against our porcine isolated ETEC strain, IPEC-J2 cells, exhibiting the F4
receptor [39], were pre-treated directly with the active dry yeast SB CNCM I-1079 prior to
ETEC challenge. Our results demonstrated a significant protective effect against ETEC F4
adhesion on IPEC-J2 porcine cells, in a dose-response fashion. Additionally, SB also showed
a positive effect on ETEC-challenged IPEC-J2 via lowering expression of several genes
involved in pro-inflammatory cascade and chemokines involved in immune responses.
Then our results showed that the strain SB CNCM I-1079 could protect porcine enterocytes
from ETEC infections by reducing bacterial adhesion and modulating the inflammatory
response. A few studies investigated the effect of S. cerevisiae strains on porcine cell lines
and found quite similar results to ours. Zanello et al. showed that on top of its ability
to agglutinate with ETEC, the strain S. cerevisiae CNCM I-3856 or its culture supernatant
could inhibit expression of genes coding for inflammatory cytokines such as IL6, IL8,
CCL20, or CXCL2 of ETEC-challenged IPEC-1 and IPI-2I porcine cells [15]. Badia et al.
evaluated the role of another yeast strain on ETEC-challenged IPI-2I cells and also noticed
a downregulation of TNFα, IL6, CCL2, CXCL8 and CCL20 gene expression [12].
To conclude, our study reported that SB CNCM I-1079 supplementation was able
to modulate the MPigut-IVM microbiota and induce differential inflammatory gene ex-
pression responses on porcine intestinal epithelial cell experiments, in the context of an
ETEC challenge. Then, its use in farms may deserve further attention to be considered as a
potential alternative solution to antibiotics to reduce the risk of ETEC infections in piglets
around weaning.
4. Materials and Methods
4.1. MPigut-IVM In Vitro Experiments
4.1.1. Fecal Samples Collection and Treatments
All animals were housed in a conventional pig farm located in the Haute-Loire area
of the Auvergne-Rhône-Alpes region in France. Piglets remained with their mother and
siblings during the suckling period. None of the piglets had signs of enteric or metabolic
disturbances. The animals did not receive any antibiotic in the 27 days prior to feces
collection day. Fecal samples from six four-week old healthy male piglets (Landrace
x Large White) were collected using sterile bottles and immediately stored under strict
anaerobiosis conditions using GENbag anaer gas pack systems (Biomerieux, Marcy L’Etoile,
France) and rapidly transported to the laboratory without freezing. Ethical review and
approval were not required for the animal study because we collected only fecal material.
4.1.2. MPigut-IVM Parameters
Five hundred mL MiniBio bioreactors (Applikon Biotechnology, Delft, The Nether-
lands) were equipped with stirrers, ports, and probes, and fecal inocula were prepared as
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previously described [16,17]. Briefly, to ensure anaerobic conditions at the beginning of
fermentations, the same volume of fecal suspension was added per bioreactor to 150 mL of
nutritive medium while flushing with O2-free N2 gas. Afterwards, during the fermentation
course, the anaerobic conditions were maintained exclusively through the activity of the
resident microbiota and by ensuring the airtightness of the bioreactors. The temperature of
the fermentation was set up at 39 ◦C and maintained inside the bioreactor medium using
an incorporated panel heater and in the mucin bead compartment using a hot water bath.
pH was maintained at 6.0 and recorded, together with the redox potential, as previously
described [16,17]. The fermentation medium was stirred at a constant speed of 300 rpm
during the total duration of the experiment. The volume of bioreactors was maintained at a
constant value of 200 mL by automatic withdrawal of the fermentation medium. Anaerobic
conditions and gas composition were checked every day by analyzing O2, CO2, CH4, and H2
using a HP 6890 gas chromatograph (Agilent Technologies, Santa Clara, CA, USA) coupled
with a TCD detector (Agilent Technologies, Santa Clara, CA, USA) and two series columns,
Molecular Sieve 5A and Porapack Q (Agilent Technologies, Santa Clara, CA, USA).
4.1.3. Mucin Bead Production and Compartment
Mucin from porcine stomach type II (Sigma-Aldrich, Saint-Louis, MO, USA) and
sodium alginate (Sigma-Aldrich, Saint-Louis, MO, USA) were used to produce mucin
beads of 4 mm diameter, as described previously [16,17]. Briefly, at the beginning of the
fermentations, 350 ± 20 mucin beads were introduced in their specific glass compart-
ments. Mucin beads were totally replaced every 48 h to ensure a continuous availability of
mucin adherent surfaces. During the time of bead replacement, the medium of the bead
compartment was kept under CO2 flushing to avoid oxygen entrance.
4.1.4. In Vitro Fermentation Procedures
Experiments in the MPigut-IVM were designed as presented on Figure 7. In vitro
fermentation procedures aimed to simulate a weaning transition which starts by giving a
pre-weaning diet during the first seven days of fermentations. This stabilization period,
as previously described, corresponds to the appropriate time to observe a stabilization of
microbiota composition and activity inside the MPigut-IVM [16,17]. At day 7, the flow of
nutritive medium was interrupted during 48 h to simulate feed deprivation [17]. At day
9, the flow of nutritive medium restarted with a post-weaning diet (defining the recovery
period). Pre-weaning and post-weaning diets for MPigut-IVM were prepared to mimic
the composition of ileal chyme of piglets as mentioned in Supplementary Table S1. All
samplings from day 7 were performed before the start of the feed deprivation period while
samplings from day 9 were collected right at the end of the feed deprivation period and
before the recovery period. Samples from the bioreactor medium and bead medium were
centrifuged at 4 ◦C, 10,000× g for 45 min. Pellets and supernatants were, respectively,
stored at −20 and −80 ◦C until analysis. After collection, mucin beads were gently washed
three times in sterile 1X PBS and stored at −20 ◦C.
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4.1.5. ETEC Culture Conditions and Challenge Procedure in The MPigut-IVM
The ETEC strain was an Enterotoxigenic E. coli Ec105 (F4, Stb+, East1+, LT+) isolated
from a diarrheic piglet (JJ Garrido, personal communication). ETEC Ec105 bacteria were
grown at 39 ◦C overnight (to be consistent with the temperature of the MPigut-IVM) in
Luria Bertani (LB) broth (BD Difco, Franklin Lakes, NJ, USA) until OD600nm = 0.6. Cultures
were centrifuged at 4 ◦C, 10,000× g for 15 min. The pellet was rinsed using sterile PBS 1X,
suspended in 1 mL of sterile PBS and 2 × 109 CFU, corresponding to 107 CFU/mL, were
inoculated into the bioreactor medium of the “ETEC” and “SBETEC” conditions at day
10 of the fermentation just before sampling.
4.1.6. SB CNCM I-1079 Supplementation
Every day, except during the feed deprivation period (48h), SB CNCM I-1079 active
dry yeast (Levucell SB, Lallemand, Blagnac, France, 2 × 1010 CFU/g) was suspended into
1 mL of sterile 1X PBS and inoculated into the MPigut-IVM to reach a final concentration of
107 CFU/mL). This dose was chosen to as close as possible to the concentration of viable
yeasts cells entering the piglet colon after a daily supplementation (Lallemand internal
data). The “ETEC” condition received a daily dose of 1 mL of sterile 1X PBS as a negative
control, except during the feed-deprivation period.
4.1.7. DNA Extraction from MPigut-IVM Samples
Total DNA was extracted from collected samples using the Quick-DNA Fecal/Soil
Microbe Miniprep Kit (Zymo Research, Irvine, CA, USA) according to the manufacturer’s
instructions. The quality of the eluted DNA was assessed by agarose gel electrophoresis.
Extracts were quantified using the Qubit dsDNA Broad Range Assay Kit (Invitrogen,
Carlsbad, CA, USA) with a Qubit 2.0 Fluorometer (Invitrogen, Carlsbad, CA, USA). Samples
were stored at −20 ◦C prior to analyses.
4.1.8. Microbial Quantification by qPCR
The list of primer pairs and their optimal conditions used for quantitative PCR of
targeted bacterial and archaeal populations in the M-Pigut-IVM are presented in Sup-
plementary Table S2 [40–44]. Real-time PCR assays were performed on a Rotor-Gene Q
(Qiagen, Venlo, NL, USA) in 20 µL reactions with QuantiFast SYBR GREEN master mix
(Qiagen, Venlo, NL, USA) or Taqman Fast Advanced Master mix (Applied Biosystems,
Foster City, California, USA) with the additions of each primer. The 16S rDNA genes
were amplified using the following program: 2 min denaturation at 95 ◦C and 10 min
denaturation at 95 ◦C; 40 and 45 cycles of 20 s at 95 ◦C and 60 s elongation, and extension
at the optimum annealing temperature and, when performing SYBR GREEN based assay,
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a melting curve step from 60 ◦C to 95 ◦C. Each reaction was run in duplicate. The melt-
ing curves of PCR amplicons from SYBR GREEN based assays were checked to ensure
primer specificity.
4.1.9. MiSeq 16S rDNA Sequencing and Bioinformatic Analysis
The DNA concentration of all samples was measured using the Qubit dsDNA High
Sensitivity Assay Kit (Invitrogen, Carlsbad, CA, USA) with a Qubit 2.0 Fluorometer (Invitro-
gen, Carlsbad, CA, USA) and diluted to 2 ng/µL prior to PCR amplification. The Bacterial
V3-V4 region of 16S rDNA and the Archaeal 16S rDNA were respectively amplified with
primers 357F 5′-CCTACGGGNGGCWGCAG-3′21 and 805R 5′-GACTACHVGGGTATCTA
ATCC-3′22 and primers 349F 5′-GYGCASCAGKCGMGAAW-3′ and 806R 5′-GGACTACVS
GGGTATCTAAT -3′23. Amplicons were generated using a Fluidigm Access Array fol-
lowed by high-throughput sequencing on an Illumina MiSeq system (Illumina, San Diego,
CA, USA) performed at the Carver Biotechnology Center of the University of Illinois
(Urbana, IL, USA). The demultiplexed paired end Illumina sequence reads in the FastQ
format were uploaded into the Galaxy instance (v.2.3.0) of the Genotoul bioinformatics
platform (http://sigenae-workbench.toulouse.inra.fr, accessed on the 10 September 2021)
to be used in the FROGS (Find Rapidly OTU with Galaxy Solution) pipeline [45]. During
the FROGS pre-process, sequences were depleted of barcode and the sequences with a
non-appropriate length or containing ambiguous bases were removed. Next, reads were
clustered into de novo operational taxonomic units (OTUs) using SWARM algorithm [46]
with, at first, a denoising step to build a very fine cluster using the minimal distance equal
to 1 and, secondly, with an aggregation distance equal to 3. Chimeras were then removed
with VSEARCH [47]. Additionally, filters were applied to the OTUs in order to remove
singletons [48,49]. The OTUs selected were taxonomically assigned using the Silva release
132 reference database [50].
4.1.10. Quantification of Short Chain Fatty Acids (SCFAs) by Gas Chromatography
SCFAs (acetate, propionate, butyrate, isobutyrate, valerate, isovalerate, and caproate)
were quantified in the bioreactor medium and bead medium by gas chromatography, as
previously described [16,17]. A mixed-model one-way Anova (lmer and Anova functions)
with time (days of fermentation) or conditions as fixed effects and fermentation experiment
as a random effect was used to compare the concentration of the main SCFAs between days
of fermentation using the R packages lme4 and car.
4.2. Porcine Intestinal Cell Line Experiments
4.2.1. Adhesion Assay of ETEC on IPEC-J2 Cells
The IPEC-J2 cell line is a non-transformed intestinal cell line derived from the ep-
ithelium of the jejunum of a neonatal non-suckling piglet maintained as a continuous
culture [51]. This cell line is generally preferred to IPI-2I cell line for adhesion tests15.
IPEC-J2 cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM)/Ham’s
F-12 (1:1) medium (InvitrogenTM Life Technologies, Carlsbad, CA, USA) supplemented
with 5% Fetal Calf Serum (FCS, PAA Laboratories GmbH, Pasching, Austria). Cells were
seeded onto 24-well tissue culture plates at 50,000 cell/well in a volume of 200 µL and
grown for 24 h in an atmosphere of 5% CO2 at 37 ◦C to allow for confluence the day
of experiment.
Active dry yeast SB CNCM I-1079 (Levucell SB 20, Lallemand SAS, Blagnac, France)
was resuspended in DMEM/Ham’s F-12 (1:1) medium (InvitrogenTM Life Technologies,
CarlSBad, CA, USA) supplemented with 5% Fetal Calf Serum (FCS, PAA Laboratories
GmbH, Pasching, Austria) and rehydrated at 37 ◦C under agitation for 30 min. ETEC
Ec105 strain was grown at 37 ◦C in LB broth (BD Difco, Franklin Lakes, NJ, USA) until
OD600 nm = 0.8–0.9 which corresponds to the concentration of 5 × 108 CFU/mL. ETEC
cells were pelleted, washed with sterile PBS and diluted with cell culture medium to reach
the concentration of 100 ETEC CFU/ IPEC-J2 cell in a final volume of 100 µL/well. The
Antibiotics 2021, 10, 1101 14 of 17
IPEC-J2 cells on 24 well-plates were first pre-incubated 3 h at 37 ◦C and 5% CO2 with SB
at the concentrations of 108, 107, and 106 CFU/well, corresponding, respectively, to 625,
62.5, and 6.25 SB cell/ IPEC-J2 cell, or with 1mL of DMEM medium in triplicates. After
3 h of incubation, IPEC-J2 cells were infected with the ETEC Ec105 strain and incubated
for additional 3 h. The entire experiment was run four times. After incubation, for three
biological replicates, IPEC-J2 cells were washed three times with sterile 1X PBS and lysed
with 1% Triton X-100 (Sigma, St. Louis, MO, USA), and serial dilutions were plated onto
LB agar to determine the number of ETEC bacteria adherent to the cells. The last replicate
was used for RNA extraction, so IPEC-J2 cells were washed three times with sterile 1X PBS
and lysed with 1 mL of NucleoZOL (Machery-Nagel, Hoerdt, France). Lysates were stored
at −80 ◦C prior to RNA isolation.
4.2.2. Incubation of ETEC-challenged MPigut-IVM Samples with an Intestinal Porcine
Cell Line
The IPI-2I cell line derived from the ileum of an adult male pig and immortalized by
transfection with an SV40 plasmid (pSV3-neo) [52], was used for this co-incubation assay
due to its potential similarity with colonic enterocytes. IPI-2I cells were maintained in
DMEM/Ham’s F-12 (1:1) (InvitrogenTM Life Technologies, Carlsbad, CA, USA) supple-
mented with 10% Fetal Calf Serum (FCS, PAA Laboratories GmbH, Pasching, Austria) and
4 mM L-glutamine (Sigma, St. Louis, MO, USA). Cells were seeded onto 48-well tissue
culture plates at 25,000 cell/well in a volume of 200 µL and grown 24 h in an atmosphere
of 5% CO2 at 37 ◦C to allow for confluence at the day of experiment. Supernatants from
fermentation medium and bead medium collected from days 7, 9, 11, 13, and 15 of fer-
mentation were filtered using 0.2 µm sterile Minisart syringe filters (Sartorius, Göttingen,
Germany) and 30 times diluted with DMEM (10% Fetal Calf Serum and 4mM L-glutamine).
The diluted samples were added in duplicates to confluent monolayers of IPI-2I cells in
48-well plates, as described above. Plates were incubated during 2 h at 37 ◦C, 5% CO2. At
the end of the incubation, supernatants were removed and IPI-2I cells were lysed by the
addition of 500 µL of NucleoZOL (Macherey-Nagel, Hoerdt, France).
4.2.3. RNA Isolation from Cell IPEC-J2 and IPI2-I lysates
Total cellular RNA was extracted from IPEC-J2 and IPI-2I lysed cells following the
NucleoZOL user manual (Macherey-Nagel, Hoerdt, France). The TURBO DNA-freeTM
kit (Applied Biosystems, Foster City, CA, USA) was used according to the manufacturer’s
instructions to prevent DNA contamination. Purity and quality of the RNA extracts
were controlled on 1% agarose gels. RNAs were then quantified using a Nanodrop
1000 spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) by measuring
the optical density at 260 nm.
4.2.4. RT-qPCR on Porcine Intestinal Cell RNA Extracts
Reverse transcription was performed using the qScript cDNA Synthesis Kit (Quantabio,
Beverly, MA, USA). Briefly, 350 ng of RNA per sample was added to 5 µL of sScript Reaction
Mix (5x) and 1 µL of qScript Reverse Transcriptase in a final volume of 15 µL. The reverse
transcription mix was incubated for 5 min at 22 ◦C, 30 min at 42 ◦C and 5 min at 85 ◦C.
The synthetized cDNAs were stored at −20 ◦C until used. Quantification of genes listed in
Supplementary Table S3 was carried out using a QuantStudioTM 12K Flex Real-Time PCR
system (Applied Biosystems, Foster City, CA, USA). The cyclophilin A and β-actin genes
were used as reference genes. PCR reactions were carried out in 96-well plates using 3 µL of
5x HOT FIREPol® EvaGreen® qPCR Mix Plus (ROX) (Solis BioDyne, Tartu, Estonia), 0.4 µL
of forward and reverse primers (Supplementary Table S3) [53], 9.2 µL of milliQ water and
2 µL of cDNA. Ten-fold dilution series of each primer pair were used as standard curves to
determine primer efficiencies. Real time PCR efficiencies were calculated according to the
equation: E = 10 (−1/slope). The appropriate reference gene and the Log2 fold change for
each gene were determined by GenEx software (http://genex.gene-quantification.info/,
accessed on the 10 September 2021). A mixed-model one-way Anova (lmer and Anova
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functions) with the different conditions as a fixed effect and replicates as a random effect
was used using the R packages lme4 and car (RStudio software version 1.0 with R software
version 3.5.1, R Development Core Team).
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/antibiotics10091101/s1, Figure S1: Relative abundance of SCFA during the ETEC and SBETEC
conditions; Figure S2: Mean relative abundances of gas produced by fermentation activity of the
microbiota inhabiting the MPigut-IVM under ETEC and SBETEC conditions (n = 2); Figure S3:
Relative abundances of the 5 main bacterial phyla in the bioreactor medium (A) and mucin beads
(B) of the MPigut-IVM during the ETEC and SBETEC conditions; Figure S4: Relative abundance of
the 15 main bacterial families in the bioreactor medium (A) and mucin beads (B) of the MPigut-IVM
during the ETEC and SBETEC conditions; Figure S5: Relative abundance of the archaeal genera in
the bioreactor medium (A) and mucin beads (B) of the MPigut-IVM during the ETEC and SBETEC
conditions; Figure S6: Quantification of bacterial and archaeal groups by qPCR in the bioreactor
medium (A), mucin beads (B) and bead medium (C) of the MPigut-IVM during the ETEC and
SBETEC conditions (n = 2); Table S1: Composition of the fermentation medium introduced in the
M-Pigut-IVM and mimicking the composition of ileal chyme of piglets when ingesting a pre- or
post-weaning diet; Table S2: Primers and probes used for quantification of bacteria and methanogenic
archaea in the M-Pigut-IVM; Table S3: Primer sets used for quantification of gene expression in
porcine epithelial cells.
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